Cargando…
CCDC6 and USP7 expression levels suggest novel treatment options in high-grade urothelial bladder cancer
BACKGROUND: The muscle invasive form of urothelial bladder cancer (UBC) is a deadly disease. Currently, the therapeutic approach of UBC is mostly based on surgery and standard chemotherapy. Biomarkers to establish appropriate drugs usage are missing. Deficiency of the tumor suppressor CCDC6 determin...
Autores principales: | Morra, Francesco, Merolla, Francesco, Criscuolo, Daniela, Insabato, Luigi, Giannella, Riccardo, Ilardi, Gennaro, Cerrato, Aniello, Visconti, Roberta, Staibano, Stefania, Celetti, Angela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381716/ https://www.ncbi.nlm.nih.gov/pubmed/30786932 http://dx.doi.org/10.1186/s13046-019-1087-1 |
Ejemplares similares
-
The combined effect of USP7 inhibitors and PARP inhibitors in hormone-sensitive and castration-resistant prostate cancer cells
por: Morra, Francesco, et al.
Publicado: (2017) -
FBXW7 and USP7 regulate CCDC6 turnover during the cell cycle and affect cancer drugs susceptibility in NSCLC
por: Morra, Francesco, et al.
Publicado: (2015) -
New combinatorial strategies to improve the PARP inhibitors efficacy in the urothelial bladder Cancer treatment
por: Criscuolo, Daniela, et al.
Publicado: (2019) -
Critical role of CCDC6 in the neoplastic growth of testicular germ cell tumors
por: Staibano, Stefania, et al.
Publicado: (2013) -
Retraction Note: Critical role of CCDC6 in the neoplastic growth of testicular germ cell tumors
por: Staibano, Stefania, et al.
Publicado: (2021)